RE:RE:RE:RE:RE:RE:Are we getting back to 30s CAD?Hydroqc, the company took 20 million out of investor pockets to conduct this trial.
The reason why Pfizer is able to get a trial done in a month is that they pay the participants more than a thousand dollars to sign up for and live within the terms of the trial.
Pfizer also pays the sites princely to recruit.
What is RVV offering? Not enough for any of the trial sites to offer as much as a blurb on their sites regarding the trial.
So, where is the 20 million being spent?
The GCG will need further funding to ensure the required level of attention in just a couple months.
Hydroqc wrote:
I don't care if you are flipping. It's a good stratgie if you know how to use it. I am not there yet.
Like most non flipping spculator of this stock, the wait of data is killing me.
Can you explain to me in what way this trial is bs. Because for what I see, compared to Merck and Pfizer trial, nothing wrong.
Revive is a tiny company but this could turn as to be an advantage. Like turning on a dime when it's needed. MF added viral load and omicron in the course of the trial. There is a parallel research trial being done at the UCSF by Dr Fahy on severe covid case. Our trial can benefit from that open label trial.
FDA is hesitating allowing EUA to Merck pill.
Pfizer pill is for severe case.
There is also place for a couple of pill maker.
And most of it, the Bucillamine molcule is acting as a possible treatement for long hauler covid.
Everyone should do their DD instead of taking advice from you or me.
Anxious to see the data
But
I don't see negativism